The Pennant Group, Inc. (PNTG)
USD 26.69
(5.0%)
USD 26.69
(5.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 329.63 Million USD | 0.94% |
| 2022 | 326.56 Million USD | -8.07% |
| 2021 | 355.24 Million USD | 11.36% |
| 2020 | 318.99 Million USD | -4.74% |
| 2019 | 334.85 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 352.26 Million USD | 2.15% |
| 2024 Q1 | 344.85 Million USD | 4.62% |
| 2023 Q3 | 319.69 Million USD | -0.98% |
| 2023 Q4 | 329.63 Million USD | 3.11% |
| 2023 FY | 329.63 Million USD | 0.94% |
| 2023 Q1 | 323.92 Million USD | -0.81% |
| 2023 Q2 | 322.87 Million USD | -0.32% |
| 2022 Q4 | 326.56 Million USD | 1.69% |
| 2022 Q1 | 331.97 Million USD | -6.55% |
| 2022 FY | 326.56 Million USD | -8.07% |
| 2022 Q3 | 321.13 Million USD | 2.46% |
| 2022 Q2 | 313.41 Million USD | -5.59% |
| 2021 Q2 | 344.5 Million USD | 3.2% |
| 2021 FY | 355.24 Million USD | 11.36% |
| 2021 Q4 | 355.24 Million USD | 2.86% |
| 2021 Q3 | 345.38 Million USD | 0.25% |
| 2021 Q1 | 333.83 Million USD | 4.65% |
| 2020 Q1 | 343.91 Million USD | 2.71% |
| 2020 Q2 | 314.63 Million USD | -8.51% |
| 2020 FY | 318.99 Million USD | -4.74% |
| 2020 Q4 | 318.99 Million USD | 2.08% |
| 2020 Q3 | 312.49 Million USD | -0.68% |
| 2019 Q1 | 225.93 Million USD | 0.0% |
| 2019 FY | 334.85 Million USD | 0.0% |
| 2019 Q4 | 334.85 Million USD | 38.94% |
| 2019 Q3 | 240.99 Million USD | 0.58% |
| 2019 Q2 | 239.6 Million USD | 6.05% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 78.181% |
| Addus HomeCare Corporation | 175.18 Million USD | -88.165% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | -230.73% |
| Amedisys, Inc. | 487.21 Million USD | 32.343% |
| Astrana Health, Inc. | 321.01 Million USD | -2.685% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 78.013% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | -186.958% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -2925.249% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -6158.439% |
| COMPASS Pathways plc | 33.04 Million USD | -897.374% |
| DocGo Inc. | 46.49 Million USD | -608.93% |
| The Ensign Group, Inc. | 1.87 Billion USD | 82.385% |
| Healthcare Services Group, Inc. | 43.63 Million USD | -655.43% |
| InnovAge Holding Corp. | 113.03 Million USD | -191.619% |
| The Joint Corp. | 16.73 Million USD | -1869.736% |
| LifeStance Health Group, Inc. | 511.04 Million USD | 35.498% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -50062.144% |
| ModivCare Inc. | 1.14 Billion USD | 71.087% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -99021.644% |
| Option Care Health, Inc. | 1.16 Billion USD | 71.74% |
| P3 Health Partners Inc. | 124.64 Million USD | -164.465% |
| P3 Health Partners Inc. | 124.64 Million USD | -164.465% |
| Surgery Partners, Inc. | 3.06 Billion USD | 89.233% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -132760.949% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | -175.117% |
| The Oncology Institute, Inc. | 119.81 Million USD | -175.117% |